Rogerio Lilenbaum Selected Research

Hemorrhage

12/2006

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rogerio Lilenbaum Research Topics

Disease

28	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2003
11	Neoplasms (Cancer) 12/2018 - 07/2005
4	Lung Neoplasms (Lung Cancer) 09/2015 - 11/2003
3	Diarrhea 12/2020 - 02/2008
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2009
3	Disease Progression 01/2015 - 11/2006
2	Exanthema (Rash) 12/2020 - 02/2008
2	Brain Neoplasms (Brain Tumor) 01/2020 - 09/2007
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015 - 01/2005
2	Neutropenia 06/2010 - 04/2007
2	Vomiting 03/2008 - 02/2008
2	Leukemia 03/2008 - 07/2005
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Pain (Aches) 12/2018
1	Multiple Chronic Conditions 09/2015
1	Weight Loss (Weight Reduction) 01/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015
1	Anorexia 03/2008
1	Hyperglycemia 03/2008
1	Infections 03/2008
1	Nausea 03/2008
1	Stomatitis 03/2008
1	Dyspnea (Shortness of Breath) 03/2008
1	Alopecia (Baldness) 02/2008
1	Fatigue 02/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2008
1	Hemoptysis 09/2007
1	Hemorrhage 12/2006
1	Pericardial Effusion 05/2006

Drug/Important Bio-Agent (IBA)

4	Cetuximab (Erbitux)FDA Link 12/2020 - 06/2005
4	Gemcitabine FDA Link 01/2015 - 05/2006
4	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 05/2006
4	Docetaxel (Taxotere)FDA Link 06/2010 - 10/2006
4	Bevacizumab (Avastin)FDA Link 05/2008 - 03/2006
2	PlatinumIBA 01/2018 - 01/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015 - 02/2008
2	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 06/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 12/2006
2	ErbB Receptors (EGF Receptor)IBA 09/2013 - 11/2010
2	Bortezomib (Velcade)FDA Link 09/2009 - 03/2006
1	AfatinibIBA 12/2020
1	pembrolizumabIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	130-nm albumin-bound paclitaxelIBA 01/2015
1	Gefitinib (Iressa)FDA Link 09/2013
1	Tyrosine Kinase InhibitorsIBA 11/2010
1	tanespimycin (17AAG)IBA 11/2010
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2010
1	Cisplatin (Platino)FDA LinkGeneric 06/2010
1	Filgrastim (Neupogen)FDA Link 06/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2010
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 09/2009
1	AlbuminsIBA 07/2009
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2009
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2008
1	Hemoglobins (Hemoglobin)IBA 03/2008
1	Monoclonal AntibodiesIBA 12/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2006
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2006
1	Celecoxib (Celebrex)FDA Link 10/2006
1	Antisense OligonucleotidesIBA 05/2006
1	aprinocarsenIBA 05/2006
1	Pemetrexed (MTA)FDA Link 03/2006
1	TER 286 (TLK286)IBA 03/2006
1	Epothilones (Epothilone)IBA 03/2006
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2003

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 01/2018 - 03/2003
10	Therapeutics 01/2018 - 01/2003
5	Radiotherapy 01/2020 - 01/2005
2	Immunotherapy 01/2020 - 01/2017
2	Combined Modality Therapy 06/2010 - 01/2005
1	Terminal Care (Care, Terminal) 01/2018
1	Time-to-Treatment 01/2018
1	Induction Chemotherapy 01/2015
1	Adjuvant Chemotherapy 09/2013
1	Combination Drug Therapy (Combination Chemotherapy) 07/2009